Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Ulixertinib (Standard) | 869886-67-9 | 99.9% | 433.33 | 200 MG
Supplier: Medchemexpress LLC 200MGHY15816
Ulixertinib is a potent, orally active, and highly selective ATP-competitive, reversible covalent inhibitor of ERK1/2 kinases. It effectively inhibits ERK2 with an IC50 of <0.3 nM, reducing phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) activity in A375 melanoma cells.
- Potent, orally active, and highly selective
- ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases
- Inhibits ERK2 with an IC50 of <0.3 nM
- Reduces phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) activity
- Demonstrates antiproliferative activity in various cell lines
- Investigated in clinical trials for multiple conditions, including solid tumors and various cancers
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?